Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Xetra  >  Merck KGaA    MRK   DE0006599905

MERCK KGAA (MRK)
Mes dernières consult.
Most popular
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

Merck KGaA : Effect Pigments for Architecture: Merck Exhibits at the Middle East Coatings Show 2012

share with twitter share with LinkedIn share with facebook
share via e-mail
0
03/05/2012 | 10:24am CEST

Darmstadt/Germany, March 5, 2012 - Merck will be presenting its effect pigments for architecture at the Middle East Coatings Show in Dubai from March 12 to 14, 2012. This exhibition is the most important platform for the coatings sector in the Middle East and the Gulf region. The focus of the exhibition will be on architectural applications, which have been seeing rapid growth in the region for the past several years. The trend toward gold and silver shades, which can currently be seen in lifestyle products and interior designs, is also being reflected in architecture.

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on MERCK KGAA
09/25 European shares stay near highs as Merkel hangs on to power
09/25 Lufthansa names former CFO Kley as new chairman
09/25 MERCK : Darmstadt, Germany, Wins Accolades for its Capital Market Communication
09/22 MERCK : Opens China's First BioReliance End-to-End Biodevelopment Center in Shan..
09/22 MERCK : SCIEX appoints new president
09/22 MERCK : starts fourth round of Accelerator program in Nairobi, Kenya
09/21 MERCK : Study Data from Merck KGaA Update Knowledge of Biosimilars [In-vivo biol..
09/21 TRANSGENE : First Half-Year 2017 in Line with Our Objectives: All Clinical Progr..
09/21 PFIZER : Phosplatin Therapeutics Announces Collaboration with Pfizer and Merck K..
09/21 MERCK : Introduces Eshmuno P Anti-A, Anti-B Chromatography Resins for Enhancemen..
More news
News from SeekingAlpha
09/24 WEEK IN REVIEW : Zai Lab Completes $150 Million U.S. IPO; Investors Push Valuati..
09/22 YOUR DAILY PHARMA SCOOP : VanEck Vectors Biotech ETF, Esperion's Growth Potentia..
09/21 Merck KGaA and Pfizer's avelumab OK'd in Europe for rare skin cancer
09/19 Merck KGaA (MKGAY) Presents At Berenberg & Goldman Sachs Sixth German Corpora..
09/05 Merck KGaA mulling sale of consumer health unit
Financials (€)
Sales 2017 15 411 M
EBIT 2017 3 288 M
Net income 2017 1 729 M
Debt 2017 9 736 M
Yield 2017 1,31%
P/E ratio 2017 23,48
P/E ratio 2018 20,50
EV / Sales 2017 1,44x
EV / Sales 2018 1,28x
Capitalization 12 472 M
Chart MERCK KGAA
Duration : Period :
Merck KGaA Technical Analysis Chart | MRK | DE0006599905 | 4-Traders
Technical analysis trends MERCK KGAA
Short TermMid-TermLong Term
TrendsBullishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 27
Average target price 109 €
Spread / Average Target 13%
EPS Revisions
Managers
NameTitle
Wolfgang Heinz Büchele Chairman-Supervisory Board
Marcus Kuhnert Chief Financial Officer
Crocifissa Attardo Member-Supervisory Board
Mechthild Auge Member-Supervisory Board
Michael Fletterich Vice Chairman-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
MERCK KGAA-2.67%14 905
ABBVIE39.59%139 451
KYOWA HAKKO KIRIN CO LTD16.69%9 660
JAZZ PHARMACEUTICALS PLC35.54%8 883
CONVATEC GROUP14.15%7 075
ZHANGZHOU PIENTZEHUANG PHARMACEUTICAL CO19.79%5 022